Researchers at the National Institutes of Health (NIH) have started dosing patients in a phase 1 trial of a new influenza vaccine candidate that aims to sidestep the annual scramble to match shots to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback